IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

October 5-6, 2021

Cambridge Health Institute’s (CHI) 6th Annual Oncolytic Virus Immunotherapy Summit

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer. Presentation: “Resurgence of the Oncolytic Measles Platform: Armed, Resurfaced and Precision Targeted.”

Visit event site

Media Inquiries

For inquiries, please contact